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Kinetic modelNitric oxide (NO) inhibits mitochondrial respiration by decreasing the apparent afﬁnity of cytochrome c
oxidase (CcO) for oxygen. Using iNOS-transfected HEK 293 cells to achieve regulated intracellular NO
production, we determined NO and O2 concentrations and mitochondrial O2 consumption by high-resolution
respirometry over a range of O2 concentrations down to nanomolar. Inhibition of respiration by NO was
reversible, and complete NO removal recovered cell respiration above its routine reference values.
Respiration was observed even at high NO concentrations, and the dependence of IC50 on [O2] exhibits a
characteristic but puzzling parabolic shape; both these features imply that CcO is protected from complete
inactivation by NO and are likely to be physiologically relevant. We present a kinetic model of CcO inhibition
by NO that efﬁciently predicts experimentally determined respiration at physiological O2 and NO
concentrations and under hypoxia, and accurately predicts the respiratory responses under hyperoxia. The
model invokes competitive and uncompetitive inhibition by binding of NO to the reduced and oxidized
forms of CcO, respectively, and suggests that dissociation of NO from reduced CcO may involve its O2-
dependent oxidation. It also explains the non-linear dependence of IC50 on O2 concentration, and the
hyperbolic increase of c50 as a function of NO concentration.cO, cytochrome c oxidase; O2,
ucible NOS; DMEM, Dulbecco's
ducible iNOS-expressing HEK
cyanide p-(triﬂuoromethoxy)
bO2, oxyhemoglobin
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Nitric oxide (NO) is a fundamental cell messenger produced in
cells by NO synthases (NOS). Many physiological actions of NO are
mediated through activation of soluble guanylate cyclase and
subsequent production of cGMP [1,2]. NO is also an effective inhibitor
of mitochondrial respiration [3–5]: it reversibly inhibits cytochrome c
oxidase (CcO), the terminal electron acceptor of the mitochondrial
respiratory system, in a process which occurs in competition with
oxygen (O2). NO, like other inhibitors that raise the K′m of CcO,
induces O2 limitation under apparently normoxic conditions. The
inhibition of mitochondrial respiration by NO has been implicated in a
wide range of physiological processes, including the regulation of theafﬁnity of mitochondrial respiration for O2 [6–10], the control of
mitochondrial generation of superoxide [11] and hydrogen peroxide
[12], the activation of hypoxia-inducible factor [13], the activation of
AMPK in astrocytes [14], the modulation of O2 delivery to tissues [15],
the modulation of calcium-mediated cell signaling in the brain [16]
and the maintenance of constant cerebral O2 consumption at varying
blood ﬂow [17]. The interaction between CcO and NO has been
implicated in various pathophysiological situations [18,19].
The molecular mechanism by which NO inhibits CcO has not been
fully deﬁned (for a review see [20]). The enzyme belongs to the
superfamily of heme-copper oxidases and contains a highly conserved
bimetallic active site composed of a high-spin heme a3 and a copper ion
CuB. The binuclear center is the binding site of the physiological
substrate O2 and of other ligands such as CN−, CO, and NO [21]. O2-
binding demands the complete reduction of the active site: two
electrons donated by cytochrome c enter CcO at CuA, from which they
are transferred, via cytochrome a, to the binuclear center. Conﬂicting
hypotheses have been proposed to explain the mechanism of CcO
inhibition byNO [22–24]; however, recent studies demonstrate that NO
interactions with CcO cannot be adequately described by a simple
competitive model and that only one NO molecule binds per binuclear
center [25]. The enzyme can bind NO either at the reduced heme a3 iron
(competitivewith O2) or at the oxidized CuB (non-competitivewith O2)
Table 1
Routine respiration, electron transport capacity, and resting and residual respiration in
Tet-iNOS 293 cells. Respiration of control cells in the absence of NO (cells were not
treated with tetracycline and no arginine was added). Routine: basal respiration using
endogenous substrates. Resting: addition of oligomycin (80 ng/ml) to measure
respiration in the absence of ATP synthesis. Uncoupled: addition of optimum FCCP
concentration (0.35 µM) for maximum ﬂow to measure the capacity of the electron
transport system. Corrections were made for residual O2 consumption (1 mMKCN at 30
to 40 µMO2). Measurements were made at 37 °C at 1×107 cells/ml in the chambers of a
high-resolution respirometer. Values are means±SD (number of independent
experiments in parentheses).
Respiratory state
endogenous substrates
Respiration
[pmol O2 ·s−1·10−6 cells]
Flux control ratio
per uncoupled rate
Routine 14.5±1.9 (8) 0.31±0.03
Resting (oligomycin) 4.2±0.4 (3) 0.089±0.004
Uncoupled (FCCP) 47.4±7.1 (8)
Residual (KCN) 0.51±0.08 (5) 0.011±0.003
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afﬁnity, to yield a Fe2+-NOnitrosyl-adduct. Throughbinding to oxidized
CuB, donation of an electron to themetal and subsequent hydration, NO
is oxidized to nitrite. The predominance of one inhibitory mechanism
over the other is controlled by the electron ﬂux through the enzyme
[29]. NO and its derivative peroxynitrite have also been reported to
irreversiblydecrease the afﬁnityof CcO forO2 [30], although this effect is
unlikely to occur at physiological NO levels.
The complexity of the cellular environment provides the ideal
setting for studying how the interplay between O2 and NO concentra-
tions determines the extent of respiratory inhibition and the O2-
dependence of iNOS-mediated NO production. However, because of
technical limitations, previous studies have not provided accurate
kinetic data at low [O2]. Additionally, in many studies sensitivity of O2
consumption toNOdonors has been examined at [O2]muchhigher than
those likely to exist in vivo. High-resolution respirometry allows
accurate determination of respiration at low O2 concentrations and
during transition to anoxia [31]. Here we present a detailed study of the
O2 kinetics of cellular respiration in intact cells producing controlled
amounts of NO [32]. Insertion of an NO sensor into the Oxygraph-2k
respirometer chamber allowed simultaneous recording of NO produc-
tion and mitochondrial respiration over an extended [O2] range. Based
on our results, we present a pseudo-equilibrium kinetic model of
inhibition of respiration by NO that accounts for both competitive and
uncompetitive inhibition of CcO and has predictive value.
2. Materials and methods
2.1. Cell culture and reagents
Tetracycline-inducible HEK 293 cells stably expressing human
iNOS (Tet-iNOS 293) were generated as described [32]. Cells were
cultured in DMEM (Invitrogen, Barcelona, Spain) containing 4.5 g/l D-
glucose, 10% (v/v) fetal-calf serum, 200 μg/ml hygromycin B and
15 μg/ml blasticidin, at 37 °C in a humidiﬁed atmospherewith 5% CO2.
S-ethylisothiourea hydrobromide (S-EITU; NOS inhibitor), L-arginine,
oligomycin and FCCP were from Sigma-Aldrich (St. Louis, MO).
Hygromycin B and blasticidin were from Invitrogen. Tetracycline was
from Calbiochem (Darmstadt, Germany).
2.2. Induction of endogenous NO production
Expression of iNOS was induced as previously described [33].
Brieﬂy, cells were incubated overnight in a complete growth medium
(without selection antibiotics) containing tetracycline (5–50 ng/ml)
and 500 μM S-EITU, a potent inhibitor of iNOS activity. Cells were
washed with L-arginine-free DMEM supplemented with 1% dialysed
fetal-calf serum to eliminate any traces of L-arginine. Cells were
incubated in L-arginine-free medium for 1 h to completely eliminate
S-EITU and tetracycline without activating NO production. Cells were
trypsinized and resuspended at 1×107 cells/ml in HBSS containing
25 mM Hepes. Endogenous NO production was triggered by addition
of L-arginine (1 mM).
2.3. Immunoblot analysis of iNOS expression
For preparation of total protein extracts, cells were trypsinized and
resuspended at 1×107 cells/ml in HBSS containing 25 mM Hepes.
Cells were spun (300 g, 5 min, 4 °C) and the pellet was resuspended in
60 μl ice-cold lysis buffer (20 mM Hepes, pH 7.5, 400 mM NaCl, 20%
(v/v) glycerol, 0.1 mM EDTA, 10 mM NaF, 10 μM Na2MoO4, 1 mM
NaVO3, 10 mM PNPP (p-nitrophenyl phosphate), and 10 mM β-
glycerophosphate) supplemented with 1 mM dithiothreitol, 1 mM
pefablock, pH 7.4, and a protease-inhibitor cocktail (Roche Diagnos-
tics, Barcelona, Spain). After 15 min on ice, cleared whole cell extracts
were obtained by recovering the supernatant after centrifugation(16,000 g, 15 min, 4 °C). Protein samples (200 μg) were resolved by
SDS/7.5%-(w/v)-PAGE and transferred to nitrocellulose membranes.
Membranes were blocked with 5% (w/v) non-fat dry milk in TBS-T
(20 mMTris/HCl, pH 7.2, 150 mMNaCl, 0.1% Tween 20) and incubated
overnight with polyclonal anti-iNOS antibody (1:2000, Transduction
Laboratories, Erembodegem, Belgium) in a blocking solution at 4 °C.
Protein bands were detected by incubation for 1 h with horseradish
peroxidase-coupled goat anti-rabbit IgG (1:5000; Vector Laboratories,
Burlingame, CA) in blocking solution at room temperature, followed
by enhanced chemiluminescence (GE Healthcare, Amersham, UK).
2.4. Simultaneous measurement of O2 consumption and NO production
O2 consumption at physiological tissue [O2] was determined by
high-resolution respirometry (Oxygraph-2k; Oroboros Instruments,
Innsbruck, Austria). Cells were trypsinized after overnight treatment
with tetracycline and resuspended in HBSS containing 25 mMHepes at
1×107 cells/ml. The instrumental background ﬂux was calculated as a
linear function of [O2] and the experimental data were corrected for the
whole range of [O2] usingDatLab software (Oroboros Instruments) [31].
To separatemitochondrial and residualO2 consumption, all resultswere
corrected for residual O2 consumption of 0.5 pmol O2 ·s−1·10−6 cells,
measured at 35 µM O2 (Table 1). Compared with CcO, residual oxygen
uptake has a lower afﬁnity for oxygen [34]. This was accounted for by
assigning a 5-fold higher c50 to residual respiration as a basis for
application of the residual O2 consumption–correction over the entire
experimental [O2] range. At air saturation, 37 °C and local barometric
pressure (92.6 kPa), the [O2] in culture medium (HBSS) was 175.7 μM
(O2 solubility factor 0.92).Measurementswere taken in cell suspensions
(2 ml) gently agitated at 37 °C in parallel Oxygraph-2k chambers; NO
production was initiated in one chamber by addition of 1 mM L-
arginine; a control run (in cells treated with the same amount of
tetracycline) was simultaneously performed in the other chamber.
Because light reverses NO-induced inhibition of respiration [35–37] O2
consumptionwasmeasured in the dark, except for analysis of inhibition
reversibility, when cell suspensions were illuminated with cold light
(Intralux 5000-1; Volpi, Switzerland). Reversibility was also studied by
adding HbO2 to quench NO or S-EITU (1 mM) to inhibit iNOS activity.
For the simultaneous measurement of endogenous NO production,
an NO sensor (ISO-NOP; World Precision Instruments, Stevenage, UK)
was inserted into the Oxygraph-2k chamber. For this, a second capillary
wasdrilled into the PVDF stopper to tightlyﬁt the 2 mmdiameter sleeve
of theNOsensor. The opening of the second capillary did not increaseO2
backdiffusion into the chamber at low [O2]. The NO sensor was
calibrated by addition of known NaNO2 concentrations under reducing
conditions (KI/H2SO4) at 37 °C. To initiate NO production, 1 mM L-
argininewas added to the chamber at 60 μMO2. This [O2] is sufﬁcient to
sustain iNOS activity [38,39]. NO concentrations were monitored until
O2 was exhausted and the NO signal returned to basal. The NO signal
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non-linear zero drift was observed before addition of L-arginine and
after zero O2 was reached. A polynomial interpolation of these sections
of the zero signal was used to construct a zero-baseline, which was
subtracted from the total signal.Fig. 1. Cell respiration in the absence or presence of low levels of NO production. O2 consu
induction (20 ng/ml tetracycline). (A,C) Oxygraph-2k traces of [O2] (blue), O2 ﬂux (red) and
plots of O2 ﬂux as a function of [O2] in the low-O2 range (b11 μM). (A,B) The hyperbolic ﬁts
relative measured ﬂux (red) calculated relative to routine ﬂux recorded at saturating [O2] (Jre
of [O2] at low levels of NO production (20 ng/ml tetracycline).2.5. Data analysis
Data were analyzed by standard least squares non-linear minimi-
zation routines,writtenwith theMatlab program(MathWorks, Natick,
MA).3. Results
3.1. Routine, uncoupled and oligomycin-inhibited respiration
Cell respiration was measured in intact Tet-iNOS 293 cells, which express iNOS upon treatment with tetracycline [32] (Fig. 2E). Cell
respiration with endogenous substrates was determined in cells not expressing iNOS, suspended in HBSS containing 25 mM Hepes. Routine O2
consumption was 14.5±1.9 pmol O2 ·s−1·10−6 cells, corrected for residual O2 consumption after inhibition of CcO. Uncoupled respiration was
three-fold higher than routine respiration (Table 1), indicating that endogenous respiration has a large potential for activation and is not
substrate-limited. Upon addition of oligomycin to inhibit ATP synthase, respiration declined to around 10% of uncoupled or 30% of routine
respiration, showing that a high proportion of routine respiration is coupled to ATP synthesis. Residual O2 consumption, measured after addition
of 1 mM KCN to inhibit CcO, was as low as 3% of routine respiration.
3.2. O2 kinetics in the absence of NO
In the absence of NO, routine respiration followed a strictly hyperbolic function, ﬁtted in the low-O2 range (b11 μM; Fig. 1A and B). The [O2] at
half-maximum ﬂux, c50 (equivalent to the apparent Km,O2) [40], was 0.65 μM±0.04 SD (n=5) for routine respiration in control cells (not
expressing iNOS) and was unaffected by addition of 1 mM L-arginine (Fig. 1A and B). The c50 agrees with the results obtained in human umbilical
vein endothelial cells [41] and ﬁbroblasts [42], and is comparable to the c50 in isolated mitochondria [40,43].
3.3. Endogenous NO production and inhibition of respiration by NO in the low-O2 range
Overnight incubation of cells with increasing concentrations of tetracycline (10–50 ng/ml) induced a concentration-dependent expression of
iNOS, as determined by western blot (Fig. 2E). Addition of the iNOS substrate L-arginine (1 mM) at 60 μM O2 immediately triggered NO
production, as shown by a steady increase of [NO] (Fig. 1C). The amount of NO produced by cells after addition of L-arginine was proportional to
the level of iNOS expression. In the physiological O2 range, even low [NO] (30 nM) caused a signiﬁcant right-shift in the O2 kinetics of cell
respiration (Fig. 1D; compare with Fig. 1B). When [O2] had dropped to ∼15 µM, NO degradation balanced NO production. iNOS activity is
progressively limited as [O2] decreases (iNOS has a high Km for O2; [38,39]). At low [O2], however, mitochondria are capable of producing NO frommption and NO production were measured in cells without (A,B) and with (C,D) iNOS
[NO] (green) as a function of time, with data points plotted at 1 s intervals. (B,D) Kinetic
(black) almost perfectly superimpose the measured data points. (D) The graph shows
f), relative calculated ﬂux from the kinetic model (black), and [NO] (green) as a function
Fig. 2. Endogenous NO production and NO-induced inhibition of cell respiration. (A–D) Kinetic plots of O2 ﬂux as a function of [O2] in the low-O2 range (b11 μM), and electrochemical
measurement of NO, in cells with iNOS induction. The graphs show relative measured ﬂux (red) calculated relative to routine ﬂux recorded at saturating [O2] (Jref), relative calculated
ﬂux from the kinetic model (black), and [NO] (green) as a function of [O2] at three levels of NO production: (A) low production (20 ng/ml tetracycline); (B,C) intermediate
production (25 ng/ml tetracycline), and (D) high production (30 ng/ml tetracycline). Traces are representative of ﬁve similar experiments. (E)Western blot showing the expression
of iNOS after overnight induction with tetracycline (10–50 ng/ml). Expression of actin was detected as a loading control.
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[O2] did not induce detectable NO production (not shown).
The rate of NO production and the maximum [NO] obtained in the experimental low-O2 regime were a function of iNOS expression (Fig. 1C
and D; Fig. 2A–D). For each experiment, the reference ﬂux (Jref), corresponding to routine respiration, was measured when [O2] was not limiting
and before addition of L-arginine. Respiration was inhibited as a complex function of O2-dependent NO production and O2 limitation of CcO
(Fig. 1D; Fig. 2A–D). Two experimental observations were particularly puzzling. First, CcOmaintained residual activity up to 2 μMNO even at [O2]
in the low μM range, in spite of the fact that CcO inhibition was already detectable at low-nM [NO] (see Fig. 2D; Fig. 5B and D). This cannot be
explained by O2 consumption by other enzyme systems and suggests that at least one NO-bound derivative of CcO is active and reduces O2.
Second, the [NO] required to inhibit CcO by 50% at any given [O2] (IC50) has an unusual parabolic dependence on [O2] (Fig. 3B; see also [24]). A
similar upward parabolic trend was obtained when NO was generated from the NO donor DETA-NONOate (Fig. S1).
The interdependence of NO and O2 concentrations generally makes it impossible to apply kinetic ﬁtting procedures that depend on variation
of substrate (O2) concentration at a constant concentration of the inhibitor (NO). We therefore applied an approach in which kinetic parameters
were ﬁtted to all data points of all experiments simultaneously.
3.4. Kinetic model of CcO inhibition by NO
Consistent with previous observations [25–28], our data cannot be adequately explained by a simple competitive inhibition model in which
NO binds to the reduced heme a3 of CcO in place of O2, especially in relation to the residual activity at high [NO] and the dependence of IC50 on
[O2]. These perplexing features would be explained if CcO catalyzed oxidation of NO, at least under some experimental conditions. We therefore
tested two minimal chemically-sound, albeit oversimpliﬁed, models that allow NO to be oxidized by O2. One considers oxidation of NO bound to
the reduced heme a3; the other, oxidation of NO bound to the oxidized CuB. Although both models were comparably successful, only the ﬁrst is
described here (see Fig. 4), since it has better independent support [45,46]. In this model, when NO occupies the heme a3, effectively competing
with O2, an alternative catalytic pathway is opened, whereby O2 transiently binds to reduced CuB, is activated to superoxide and is forced to react
with NO to yield peroxynitrite, which spontaneously converts to nitrite (NO2−) [46].
Fig. 3. Relationship between NO concentration and the degree of inhibition of respiration. (A) Effect of [NO] on the relative O2 ﬂux, calculated from the kinetic parameters at constant
[O2] of 10 μM (green), 30 μM (red), 50 μM (black), 90 μM (yellow), or 180 μM (blue). (B) IC50 (μM) as a function of [O2]; open symbols are from experiments carried out in the low
[O2] range; closed symbols from the high [O2] range. The line is drawn according to Eq. (4), using the parameters reported in the text.
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concentrations of O2 and NO is given by the following partition function:
CcOtot½  = CcOr½  1 + O2½ = Km1 + NO½ = KicNO + O2½  NO½ = Km2KicNO + O2½  NO½ = KuNOKm1ð Þ ð1Þ
where CcOtot is the total (all species) CcO; CcOr is the reduced CcO; Km1 is the Km of CcO for O2 in the absence of NO; Km2 is the Km of CcO for O2
when NO is bound to heme a3; KicNO is the competitive inhibition constant of NO for CcO, and KuNO is the uncompetitive inhibition constant of NO
for CcO.
The rate of respiration is described by Eq. (2):
V =
CcOtot½ Vmax1 O2½ KuNOKm2KicNO + r O2½  NO½ Km1KuNOð Þ
Km1Km2KicNOKuNO + O2½ Km2KicNOKuNO + O2½  NO½ Km2KicNO + NO½ Km1Km2KuNO + O2½  NO½ Km1KuNO
ð2Þ
where r represents the ratio Vmax2/Vmax1 (which we estimate at ∼1.35). Notice that the oxidative dissociation of NO bound to CuB as nitrite ion
governed by VNO (see Fig. 4) does not involve O2 consumption and therefore does not appear in Eq. (2).
Analysis by standard least squares non-linear minimization routines yielded the following parameter values: Km1=0.81 μM,
Vmax1=16.5 pmol O2 ·s−1·10−6 cells, KicNO=3.63 nM, Km2=520 μM and Vmax2=22 pmol O2 ·s−1·10−6 cells. KuNO was higher than the
usual NO concentrations achieved in this study, thus it was poorly determined and could be dropped from the ﬁt. The best ﬁt to the experimental
data requires the afﬁnity of O2 for CcO to be modulated by enzyme-bound NO, such that the species CcOrNO (with NO bound to heme a3) has a
higher Km for O2 (Km2) than the uninhibited enzyme (Km1). This is consistent with the inhibitory activity of NO and the lower afﬁnity of O2 for Cu.
The model was applied to all the data from experiments carried out at low [O2] (some of which are presented in Fig. 1C and D and Fig. 2A–D).
The kinetic parameters thus obtained were used to simulate the experimental traces collected over a 4-fold extended [O2] range, which are
shown in Fig. 5, and to generate the lines in Fig. 3A and B. The experiments in the high-O2 range were designed to test the predictive ability of the
model beyond the range over which the parameters were ﬁtted.
In theminimummodel of linear competitive inhibition [22], the apparent inhibition constant, K′i, determines the proportionality bywhich the
c50 (the [O2] required to achieve half Vmax at any given [NO]) is increased as a linear function of [NO]. This model fails to explain the non-linear
dependence of c50 on [NO] that we observed in intact cells (not shown). A more accurate prediction is given by the following equation, derived
from our model:
c50 =
KuNOKm1Km2 KicNO + NO½ ð Þ
KicNOKuNOKm2 + NO½ KuNOKm1 + NO½ KicNOKm2
ð3Þ
The IC50 is deﬁned as the [NO] that inhibits mitochondrial respiration by 50% relative to ﬂux at the same [O2] in the absence of NO. In the
competitive model, IC50 is a linear function of [O2] [22]; our data in intact cells show that IC50 is a non-linear function of [O2] (Fig. 3B), which our
model predicts to be determined as follows:
IC50 =
KuNOKicNOKm2 Km1 + O2½ ð Þ
Km1KuNOKm2 + O2½ Km2KicNO−2rK2m1KuNO− 2r−1ð Þ O2½ KuNOKm1
ð4Þ
where r represents the ratio Vmax2/Vmax1.
We are aware of the limitations of the proposed model, which (i) assumes that the cell's reducing pressure is constant and neglects the
reduction steps of the catalytic cycle, and (ii) may attribute to CcO roles played by other components of the cell. These limitations, however, do
Fig. 4. Scheme representing the proposed model of NO-inhibition of CcO. A simpliﬁed catalytic cycle under constant reducing pressure is adopted for CcO in the absence of NO,
described by the steady state parameters Km1 and Vmax1. NO is assumed to bind to both the fully reduced and the fully oxidized states of the enzyme, with the dissociation constants
KicNO and KuNO respectively. When NO binds to the reduced heme a3 dissociation can also occur after oxidation of the gas to nitrate ion, thanks to a molecule of O2 activated by CuB
(see text and Refs. [45,46]); this goes through a complete alternative catalytic cycle described by the steady state parameters Km2 and Vmax2. NO bound to CuB can in turn be oxidized
by the metal and be released as nitrite ion (NO2−) in a reaction that does not require O2 (described by VNO). Dashed arrows indicate reactions described in the literature but that occur
only to a minimal extent under our experimental conditions and can be safely neglected in the quantitative analysis of our data. CcOr, reduced CcO; CcOrNO, CcOr with NO bound to
heme a3; O2CcOrNO, CcOr with NO bound to heme a3 and O2 bound to CuB; CcOo, oxidized CcO; CcOoNO, CcOo with NO bound to CuB.
562 E. Aguirre et al. / Biochimica et Biophysica Acta 1797 (2010) 557–565not seem to us to be major drawbacks since the aim of the model is to describe cell respiration under NO stress via a chemically sound, though
oversimpliﬁed, reaction mechanism.
3.5. NO dynamics in the low- and high-O2 ranges
At high levels of iNOS expression (50 ng/ml tetracycline) NO production in the low-O2 range is sufﬁciently fast to reach high, near steady-
state NO concentrations of 1.5 μM within 10–15 min, when O2 drops to 30 μM and becomes limiting for NO production (Fig. 5A and B). In the
high-O2 range, the further increase of [NO] from 10 to 40 min is modest (from 1.5 to 2 μM), indicating a near-balance between NO production and
utilization at NO concentrations in the upper pathophysiological range (Fig. 5C and D). In contrast, at low levels of iNOS expression (20 ng/ml
tetracycline) in the low-O2 range, respiration is less inhibited and 30 μM O2 is reached in less than 5 min (Fig. 5E), at a time when the steep
increase in [NO] continues near-linearly at high [O2] (Fig. 5G). There is an additional period of approximately 40 min in the high-O2 range, during
which net NO production is positive and hence NO accumulates, until again at around 30 μMO2 the balance shifts to NO degradation and the [NO]
level falls (Fig. 5G and H). A plot of critical [O2] for limitation of NO production, against [NO] is shown in Fig. 6. Although the critical [O2] is a
complex function of iNOS expression levels and O2 range, it was actually restricted to a surprisingly narrow range under all experimental
conditions.
3.6. Reversible inhibition and NO-induced activation of the cellular metabolic state
Weperformed a series of experiments to study the reversibility of the inhibition. Addition of HbO2 to cells producing high levels of NO (50 ng/
ml tetracycline and 1 mM L-arginine) resulted not only in full recovery but in a signiﬁcant increase in cellular respiration above the routine
reference level observed before L-arginine addition (Fig. 7A). Respiration was also recovered after inhibition of iNOS activity with S-EITU (1 mM;
not shown). No irreversible effects were observed up to 1.8 μMNO. Moreover, when the cell suspension was illuminated with a cold light source
at 60 µM O2, the respiration rate immediately increased above the reference level; this reﬂects the photochemical dissociation of the reduced
heme a3–NO complex [35–37], again revealing the NO-induced stimulation of cell respiration (Fig. 7B). Light had no effect on respiration in the
absence of NO (not shown).
We deﬁne the stimulation factor, F, as the ratio of Vmax1 after NO removal to Vmax1 before L-arginine addition (Fig. 7C). Fwas usually between 1
and 1.5 and we attribute it to the accumulation of reduced cytochrome c and a decline in mitochondrial membrane potential caused by CcO
inhibition. Stimulation causes Vmax1 (and Vmax2) to be variable, rather than constant, parameters; however, ourmodel assumes constant reducing
pressure and neglects the stimulation effect. Nevertheless, stimulation is signiﬁcant only at high [NO], where Vmax2 predominates, while at low
[NO] the absence of stimulation is associated with predominance of Vmax1. Therefore the stimulation effect is partially reﬂected in the ratio of
Vmax2 to Vmax1 (r=Vmax2/Vmax1). A plot of normalized ﬂuxes predicted from the kinetic model plotted against experimentally determined ﬂuxes
is depicted in Fig. 7D.
Fig. 5. NO production and NO-induced inhibition of respiration over a standard (A,B,E,F) or extended (C,D,G,H) [O2] range. O2 consumption and NO production were measured at
high (50 ng/ml tetracycline; A–D) and low (20 ng/ml tetracycline; E–H) iNOS activities. (A,C,E,G) Oxygraph-2k traces of [O2] (blue), O2 ﬂux (red) and [NO] (green) as a function of
time, with data points plotted at 1 s intervals. (B,D,F,H) Relative measured ﬂux (red), estimated ﬂux from the kinetic model (black) and [NO] (green) as a function of [O2]. Traces are
representative of three similar experiments.
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We present a detailed study of the O2 kinetics of cellular respiration
at varying concentrations of endogenous NO over the pathophysiolog-Fig. 6. Critical [O2] for limitation of NO production. Critical [O2] for net NO production,
below which [NO] declines. High [NO] corresponds to high iNOS activities in the low-
and high-O2 ranges (full and open circles, respectively).ical range. Based on the results, we propose a kinetic model of NO-
induced inhibition of cellular respiration that explains the experimental
data andhaspredictive value. Themodel assumes that the systemcanbe
treated under the pseudo-equilibrium approximation and that two
cycles, each characterized by its own Km and Vmax, are possible, one for
NO-free and one for NO-bound CcO. The pseudo-equilibrium assump-
tion is unrealistic, but greatly simpliﬁes the analysis at the expense of
some parameters becoming apparent, rather than real, kinetic con-
stants. The model invokes both competitive inhibition (at the heme a3
site) anduncompetitive inhibition (at CuB), as previouslydescribed [25–
28]. The details of the complex catalytic cycle of CcO are ignored, in
particular in relation to the reduction intermediates. Vmax1 corresponds
to routine respirationof the intact cell at saturating [O2] in the absenceof
NO. Routine respiration is regulated at a modest level of activity,
signiﬁcantly below the maximum capacity of the electron transport
system, and thus below the true Vmax for CcO [41], as shown by the
results listed inTable 1 andby theNO-induced stimulationof respiration
(Fig. 7A and B). Notably, increases in [NO] that are unable to inhibit cell
respiration reduce CcO, and the excess capacity of the enzyme is able to
maintain O2 consumption in the cell [47].
Fig. 7. Stimulation of respiration following NO removal. (A,B) Oxygraph traces of [O2] (blue) and O2 ﬂux (red) in cells treated with tetracycline (50 ng/ml), showing the inhibition of
respiration induced by the addition of L-arginine (1 mM). Subsequent addition of HbO2 (A) or illumination with a cold light source (B) stimulated respiration (Js) above the initial
reference level. (C) Stimulation factor (F= Js/Jref) as a function of [NO]. (D) Normalized ﬂuxes predicted from the kinetic model (hyperbolic approximation, see Supporting
information) plotted against experimentally determined ﬂuxes.
564 E. Aguirre et al. / Biochimica et Biophysica Acta 1797 (2010) 557–565The model is designed to incorporate two important observations
from previous studies on puriﬁed CcO or its model compounds. First, it
allowsNObound to oxidized CcO to act as a slow reductant, rather than
as an inhibitor, by donating its unpaired electron. The resulting
nitrosonium ion (NO+), dissociates via conversion to nitrite (NO2−) in a
non-redox reaction with a water molecule [27,48]. Second, the model
includes an NO-dissociation cycle (for the derivative CcOrNO) that
consumes O2, albeit with a high Km (Km2). This can account for the low
O2 consumption we observed experimentally at high [NO]. Although
this reaction has not been observed unequivocally in isolated CcO, and
was not detected in speciﬁcally designed experiments [49], it has been
suggested by Pearce et al. [45], and has been directly demonstrated for
amodel compoundmimicking the binuclear site of CcO synthesized by
Collman et al. [46]. Our data cannot resolve this issue, due to the
complexity of the system studied (whole cells, rather than puriﬁed
CcO). However, we unequivocally observed respiration at NO
concentrations that should fully inhibit CcO activity in the absence of
a mechanism like the one proposed in Fig. 4 and Refs. [45,46].
Our model ﬁts the experimental data and is compatible with what
is known about the interaction between CcO and NO [25,45,46];
however, it may not provide a complete description of the observed
O2 ﬂuxes in intact living cells. Other reactions between O2 and NO are
possible, either spontaneous or catalyzed by cell components other
than CcO. These reactions, as well as functions played by other cellular
components, would contribute to O2 consumption and in our model
would be wrongly attributed to CcO. Nonetheless, our model provides
a chemically sound quantitative description of our data and has
predictive value. We also tested a variant model, in which O2 oxidizes
the NO molecule bound to CuB, rather than the one bound to heme a3
[50]. Although this variant accurately ﬁts the experimental data, it was
discarded because it lacks independent support; indeed no such
reaction was reported for the synthetic model of CcO [46].
Themost important feature of themodel presented here is that the
relative population of the catalytically active species O2CcOrNO
(represented by the term [O2][NO]/Km2KicNO in Eq. (1)) is propor-tional to the product of the concentrations of NO and O2. This provides
an explanation for how the enzyme can be active at relatively high
inhibitor concentrations and also explains the non-linear IC50 vs. [O2]
plot (Fig. 3B). An IC50 vs. [O2] plot similar to ours was presented by
Koivisto et al. [24]; however, these authors proposed that two O2
molecules need to bind to CcO to compete with NO, which is unlikely.
Our hypothesis provides a sounder solution to this problem. More
recently, using published data mainly obtained with NO donors, an
IC50 vs. [O2] plot similar to ours has been reported [51].
In conclusion, we show the dependence of NO production on [O2]
and the interplay between O2 and NO concentrations in determining
cell respiration. In spite of its complexity, this interplay can be
described by a relatively simple and chemically sound kinetic model.
The control of respiration by NO regulates O2 gradients in the cell,
redox signaling and apoptosis [52]. Furthermore, interactions of NO
with mitochondria have important implications for ischemic biology
[33,53] and hypoxic vasodilation [54], and their understanding will
help clarify the mechanisms by which NO exerts cardioprotective
actions [55].
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